Patient‐reported outcomes from the investigational device exemption study of the Tablo hemodialysis system

INTRODUCTION: We recently completed an Investigational Device Exemption (IDE) study in which 30 patients were enrolled (13 patients previously on home hemodialysis (HHD) and 17 patients new to HHD) and treated with the Tablo Hemodialysis System (Outset Medical, Inc., San Jose, CA) for 8 weeks in‐cen...

Descripción completa

Detalles Bibliográficos
Autores principales: Chertow, Glenn M., Alvarez, Luis, Plumb, Troy J., Prichard, Sarah S., Aragon, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692883/
https://www.ncbi.nlm.nih.gov/pubmed/32851807
http://dx.doi.org/10.1111/hdi.12869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692883/
https://www.ncbi.nlm.nih.gov/pubmed/32851807
http://dx.doi.org/10.1111/hdi.12869

Ejemplares similares